Riskpilot← Back to searchSign inGet full accessHINNA DYREKLINIKK AS
ASActiveOrg 922673349Auglendsmyrå 2, 4016 StavangerVeterinary activities · NACE 7500Est. 201916 employees
Revenue 2024
NOK 24,3M
-1% vs 2023
EBITDA margin
28.3%
-21% vs 2023
Equity ratio
0.6%
Financial strength
Net profit 2024
NOK 4,7M
-23% vs 2023
| Revenue | NOK 24,3M | -1% |
| EBITDA | NOK 6,9M | -21% |
| Net profit | NOK 4,7M | -23% |
| Total assets | NOK 10,2M | -17% |
| Equity | NOK 57K | +87% |
| Employees | 16 | — |
Legal name
HINNA DYREKLINIKK AS
Org number
922673349
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
27. april 2019
Share capital
NOK 30 000
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drive veterinærvirksomhet og annen virksomhet som står i forbindelse med dette.
Address
Auglendsmyrå 2, 4016 Stavanger
Phone
+4751819090
Email
post@hinnadyreklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 18 394 | 20 327 | 21 673 | 24 622 | 24 263 |
| Staff expenses | −6 961 | −8 640 | −9 665 | −9 585 | −10 625 |
| EBITDA | 5 526 | 5 506 | 6 092 | 8 704 | 6 871 |
| Depreciation & amort. | −1 215 | −1 272 | −822 | −897 | −1 002 |
| EBIT | 4 311 | 4 234 | 5 270 | 7 807 | 5 869 |
| Net financials | 26 | 16 | 33 | 72 | 200 |
| Profit before tax | 4 337 | 4 250 | 5 303 | 7 880 | 6 069 |
| Tax | 955 | 935 | 1 167 | 1 734 | 1 336 |
| Net profit | 3 382 | 3 315 | 4 136 | 6 146 | 4 733 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 13 210 | 11 630 | 7 261 | 12 313 | 10 233 |
| Equity | 3 833 | 7 148 | 67 | 31 | 57 |
| Long-term debt | 4 876 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 500 | 4 482 | 7 193 | 12 283 | 10 176 |
| Total debt | 9 377 | 4 482 | 7 193 | 12 283 | 10 176 |
EBITDA margin
28.3%
This company
15.8%
Market median
+79% vs market
20202024
Equity ratio
0.6%
This company
38.2%
Market median
-98% vs market
20202024
Return on equity
8268.4%
This company
18.4%
Market median
+44837% vs market
20202024
Net profit margin
19.5%
This company
8.1%
Market median
+141% vs market
20202024
Asset turnover
2.37×
This company
1.12×
Market median
+112% vs market
20202024
Debt / equity
177.77×
This company
0.62×
Market median
-28573% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IO Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (1) | ||
KF Chief Executive Officer | Chief Executive Officer | 2019 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (2) | ||
| Chairman | 2019 – 2022 | |
| Board of Directors | 2019 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ax Vi Vet No Holding As
HINNA DYREKLINIKK AS Board members of HINNA DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Fjell | Chief Executive Officer | 0 companies |
| Ingvil Ovedal | Chief Executive Officer | 0 companies |
| Eirik Nilssen | Chairman | 0 companies |
| Kaja Elise Stokstad | Chairman | 0 companies |
| Svein Ingve Netland | Board of Directors | 0 companies |